4
Changes in Ownership
IOVANCE BIOTHERAPEUTICS, INC. Filed Acc 0001104659-24-068771
Interim CEO & General Counsel gave up 4,426 shares (to pay taxes)
- Interim CEO & General Counsel acquired 10,417 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
Table I: Non-derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Vogt Frederick G Interim CEO & General Counsel | 2024-06-03 | Option exercise | +10,417 | 151,751 | D: show line 1 in the form | ||
| Vogt Frederick G Interim CEO & General Counsel | 2024-06-03 | Shares withheld for taxes | −4,426 | $8.37 | $37,046 | 147,325 | D: show line 2 in the form |
Table II: Derivative
| Insider | Date | Transaction | Shares | Price | Value | Exercise | Expires | Underlying | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|
| Vogt Frederick G Interim CEO & General Counsel | 2024-06-03 | Option exercise · Restricted Stock Units | −10,417 | 72,921 | D: show line 3 in the form |
Loading xslF345X05/tm2416581-1_4seq1.xml…